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Background: Acute posterolateral left ventricular ischemia in sheep results in
ischemic mitral regurgitation, but the effects of ischemia in other left ventricular
regions on ischemic mitral regurgitation is unknown.
Methods: Six adult sheep had radiopaque markers placed on the left ventricle, mitral
annulus, and anterior and posterior mitral leaflets at the valve center and near the
anterior and posterior commissures. After 6 to 8 days, animals were studied with
biplane videofluoroscopy and transesophageal echocardiography before and during
sequential balloon occlusion of the left anterior descending, distal left circumflex,
and proximal left circumflex coronary arteries. Time of valve closure was defined as
the time when the distance between leaflet edge markers reached its minimum
plateau, and systolic leaflet edge separation distance was calculated on the basis of
left ventricular ejection.
Results: Only proximal left circumflex coronary artery occlusion resulted in
ischemic mitral regurgitation, which was central and holosystolic. Delayed valve
closure (anterior commissure, 58  29 vs 92  24 ms; valve center, 52  26 vs
92  23 ms; posterior commissure, 60  30 vs 94  14 ms; all P  .05) and
increased leaflet edge separation distance during ejection (mean increase, 2.2 
1.5 mm, 2.1  1.9 mm, and 2.1  1.5 mm at the anterior commissure, valve
center, and posterior commissure, respectively; P  .05 for all) was seen during
proximal left circumflex coronary artery occlusion but not during left anterior
descending or distal left circumflex coronary artery occlusion. Ischemic mitral
regurgitation was associated with a 19%  10% increase in mitral annular area,
and displacement of both papillary muscle tips away from the septal annulus at
end systole.
Conclusions: Acute ischemic mitral regurgitation in sheep occurred only after
proximal left circumflex coronary artery occlusion along with delayed valve closure
in early systole and increased leaflet edge separation throughout ejection in all 3
leaflet coaptation sites. The degree of left ventricular systolic dysfunction induced
did not correlate with ischemic mitral regurgitation, but both altered valvular and
subvalvular 3-dimensional geometry were necessary to produce ischemic mitral
regurgitation during acute left ventricular ischemia.
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Ischemic mitral regurgitation (IMR) presents a chal-lenging clinical problem associated with subopti-mal surgical results and poor prognosis caused bythe underlying left ventricular (LV) dysfunctioncaused by myocardial ischemia and infarction.1-3Mitral valve repair might offer better outcomes in
this patient population than valve replacement,4 but no
standardized repair methods exist on the basis of the various
leaflet-motion abnormalities seen. Despite a plethora of
experimental and clinical studies investigating the 3-dimen-
sional (3-D) valvular and subvalvular geometric perturba-
tions associated with IMR, knowledge of the precise mech-
anisms responsible for valvular incompetence remains
elusive. Mitral annular changes,5,6 systolic leaflet apical
tethering,6-10 more spherical LV shape,11,12 and impaired
LV systolic function13 have all been suggested as contrib-
uting factors, but a more detailed understanding of the
underlying mechanisms is needed to guide better surgical
treatment.
In prior studies with radiopaque marker methods in
sheep, we showed that proximal left circumflex (LCx) cor-
onary artery occlusion results in acute posterolateral LV
ischemia and IMR caused by delayed valve closure during
very early systole5 and perturbed leaflet 3-D geometry
throughout ejection.14 Others have attributed acute IMR in
similar animal models to papillary muscle discoordination
at end systole.10 These and related studies had limitations,
one of which was that neither the timing nor the location of
the regurgitant jet could be determined from transthorac-
ic5,14 or subdiaphragmatic10 echocardiography. Therefore
the observed 3-D perturbations in valvular and subvalvular
dynamic geometry arising during acute ischemia could not
be correlated either spatially or temporally with the echo-
cardiographic regurgitant leak nor could the pathogenesis of
IMR as a function of ischemia in other LV regions be
examined. Our previous experiments examined leaflet dy-
namics only at the central edge of the leaflets not allowing
detection of possible changes occurring near the commis-
sures; also, the effects of ischemia in other LV regions on
mitral competence and valvular dynamics was not exam-
ined. To gain more insight into the mechanistic pathogen-
esis of IMR, we used transesophageal Doppler echocardi-
ography and biplane videofluoroscopy of multiple leaflet
markers to study the effects of posterolateral LV ischemia
caused by proximal LCx (pLCx) coronary artery occlusion
and acute ischemia in other LV regions (ie, occlusion of the
left anterior descending [LAD] coronary artery or distal
LCx [dLCx] coronary artery) on mitral valve 3-D dynamic
geometry and competence.
Methods
Surgical Preparation
The surgical preparation has previously been described15 and will
be presented only in abbreviated form. Six adult sheep (71  13
kg) were premedicated with ketamine (25 mg/kg administered
intramuscularly), and anesthesia was induced with sodium thio-
pental (6.8 mg/kg administered intravenously) and maintained
with inhalational isoflurane (1%-2.5%). Through a left thoracot-
omy, 8 tantalum myocardial markers (inner diameter, 0.8 mm;
outer diameter, 1.3 mm; length, 1.5-3.0 mm) were inserted in the
LV epicardial layer along 4 equally spaced longitudinal meridians,
as shown in Figure 1. After establishment of cardiopulmonary
bypass with the heart arrested, a single tantalum marker was placed
at the tip and base of both papillary muscles (Figure 1), and 8
tantalum markers were sutured around the circumference of the
mitral annulus (one near each commissure and 3 along the septal
and lateral annulus, Figure 2). Two miniature gold markers were
sutured at the central edge of each leaflet, and 4 additional markers
were sewn on each leaflet edge halfway between the central leaflet
edge marker and the anterior and posterior commissures (Figure
2). After completion of marker placement, the animal was re-
warmed, the atriotomy was closed, the crossclamp was removed,
the heart was resuscitated, and the animal was weaned from
bypass. Cardiopulmonary bypass time was 81  6 minutes, with
an aortic crossclamp time of 61  3 minutes. A micromanometer
pressure transducer (PA4.5-X6, Konigsberg Instruments, Inc) was
placed in the LV chamber through the apex. Proper myocardial
marker position was confirmed in all animals on postmortem
examination.
Experimental Protocol
After 7  1 (mean 1 SD) days, each animal was taken to the
cardiac catheterization laboratory, sedated with ketamine (1-4 mg
 kg1  h1 administered intravenously) and diazepam (5 mg
intravenous bolus as needed), intubated, and mechanically venti-
lated (veterinary anesthesia ventilator 2000, Halowell EMC). An
esmolol intravenous infusion (20-50 g  kg1  min1) mini-
mized reflex sympathetic responses. Coronary artery balloon oc-
clusion (1-4 minutes), as described previously,5 was performed at
3 locations in sequential fashion: proximal LAD coronary artery
(proximal to the first diagonal), dLCx coronary artery (distal to the
second obtuse marginal), and pLCx coronary artery (proximal to
the first obtuse marginal).
Videofluoroscopic marker image recordings were acquired be-
fore and during induction of ischemia at each location with simul-
taneous transesophageal color Doppler echocardiography to assess
mitral regurgitation (MR). After each data-acquisition run, a 3- to
5-minute period of stabilization was allowed before data acquisi-
tions were repeated. MR was graded on the basis of regurgitant jet
extent and width as none (0), mild (1), moderate (2), moderate
to severe (3), or severe (4) by an experienced echocardiogra-
pher (D.L.).
All animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by the Na-
tional Society for Medical Research and the “Guide for Care and
Use of Laboratory Animals” prepared by the National Academy of
Sciences and published by the National Institutes of Health
(DHEW NIHG publication no. 85-23, revised 1985). This study
was approved by the Stanford University Medical School Labora-
tory Research Animal Review committee and conducted according
to Stanford University policy.
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Data Acquisition
Images were acquired with the animal in the right lateral decubitus
position with a Philips Optimus 2000 biplane Lateral ARC 2/Poly
DIAGNOST C2 system (Philips Medical Systems), with the image
intensifier in the 9-inch fluoroscopic mode. Data from 2 radio-
graphic views were digitized and merged to yield 3-D coordinates
for each of the radiopaque markers every 16.7 ms by using
custom-designed software.16 Ascending aortic pressure, LV pres-
sure, and electrocardiographic voltage signals were digitized and
recorded simultaneously during marker data acquisition.
Data Analysis
Hemodynamics and cardiac cycle timing markers. Two to 3
consecutive steady-state beats immediately before occlusion of
any coronary artery were averaged and defined as preischemia data
for each animal. Similarly, 2 to 3 beats during occlusion of the
LAD, dLCx, and pLCx coronary arteries were averaged and de-
fined as ischemia data. During each cardiac cycle, end systole was
defined as the time of the videofluoroscopic frame containing the
point of peak negative rate of LV pressure decrease (dP/dt),
whereas end diastole was defined as the videofluoroscopic frame
containing the peak of the electrocardiographic R wave. Instanta-
neous LV volume was calculated from the positions of the epicar-
dial LV markers and annular markers by using a space-filling
multiple tetrahedral volume method for each frame (ie, every 16.7
ms).17 Although myocardial volume is included in calculation of
LV volume, relative changes in LV chamber size are accurately
measured by using the epicardial marker coordinates.
Mitral leaflet and annular dynamics. Mitral valve-closure
time was defined as the time at which leaflet edge separation
reached its minimum plateau. Leaflet separation was measured as
distance in 3-D space between the 2 leaflet edge markers at the
center of the valve and toward the anterior and posterior commis-
sures (Figure 2). Leaflet edge separation throughout the cardiac
cycle for each animal was represented by a unique continuous
function generated by spline-fitting computer software (S-Plus,
Mathsoft, Inc) to identify objectively the time of valve closure.
Valve closure for each leaflet region (anterior commissure, valve
center, and posterior commissure) was defined as the time after end
diastole at which the first time derivative with respect to time of
the associated spline function decreased to less than 0.002 cm/s (a
value reflecting the beginning of the leaflet edge distance mini-
mum plateau). Leaflet edge separation at each leaflet edge marker
pair was determined for each experimental condition at 25%, 50%,
75%, and 100% of LV ejected LV stroke volume to assess leaflet
separation during systole. Mitral annular area was calculated as the
sum of the areas of 8 triangles formed by consecutive adjacent
marker pairs on the annulus and the annular centroid. The septal-
lateral (S-L) diameter of the annulus (clinically referred to as the
anterior-posterior dimension) was calculated as the distance in 3-D
space between the 2 markers placed in the middle of the septal and
lateral mitral annulus, respectively. The commissure-commissure
(C-C) diameter was calculated as the distance between the 2
annular commissural markers. Papillary muscle percentage short-
ening was determined as the change from end diastole to end
systole in distance between the papillary muscle tip and base
markers divided by the distance at end diastole.
Statistical analysis. All data are reported as means  1 SD.
Hemodynamic and marker-derived data from 2 to 3 consecutive
steady-state beats that were time aligned at end diastole and data
from these beats were averaged for each animal. The data were
analyzed over 20 frames before and 20 frames after end diastole
(total time of 667 ms), thereby allowing assessment of variables
over the entire cardiac cycle. Data were compared by using the
Student t test for paired comparisons and repeated-measures anal-
ysis of variance (ANOVA) when appropriate.
Figure 1. Miniature radiopaque marker array (filled circles, myo-
cardial; filled squares, papillary) used for the left ventricle in this
experimental study. PPM, Posterior papillary muscle; APM, an-
terior papillary muscle.
Figure 2. Schematic diagram of the implanted mitral annular
(filled squares) and mitral leaflet (filled circles) markers. Leaflet
edge marker pairs were implanted at the valve center (CENT),
halfway between the center and the anterior commissure
(ACOM), and halfway between the center and the posterior com-
missure (PCOM). AML, Anterior mitral leaflet; PML, posterior
mitral leaflet.
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Results
Table 1 summarizes the hemodynamic variables during
acute occlusion of the LAD, dLCx, and pLCx coronary
arteries relative to the corresponding preischemic control
conditions. LV dP/dt decreased a similar amount during
ischemia in the 3 different LV regions (32%  7%, 32% 
12%, and 36%  24% for LAD, dLCx, and pLCx coronary
arteries, respectively; P  .88, ANOVA), as did peak LV
pressure (28%  12%, 26%  14%, and 37%  15% for
LAD, dLCx, and pLCx coronary arteries, respectively; P 
.19, ANOVA) and stroke volume (22% 11%, 21% 9%,
and 26%  13% for LAD, dLCx, and pLCx coronary
arteries, respectively; P  .52, ANOVA). Heart rate, LV
dP/dt, LV end-diastolic and end-systolic volumes, LV end-
diastolic and end-systolic pressures, stroke volume, and
peak LV pressure during each arterial occlusion did not
differ from those seen in the other 2 ischemic interventions
(P .05, ANOVA). The difference in end-diastolic volume
among the 3 interventions approached significance (P 
.056, ANOVA); a paired t test with Bonferroni correction
revealed that end-diastolic volume was significantly differ-
ent only between the dLCX and pLCX coronary artery
occlusions, and the increase in LV end-diastolic volume
during ischemia was significant only for pLCX coronary
artery occlusion. Thus LV systolic function was decreased
by approximately the same extent during the 3 different
ischemic insults. Heart rate did not change.
Mitral Regurgitation
The amount of MR present during baseline conditions be-
fore each ischemic insult did not change throughout the
experiment. The average baseline MR grade was 0.5 
0.5, with 2 animals having no MR, 2 having trace MR, and
2 having mild MR. During LAD and dLCx coronary artery
occlusion, MR increased slightly to0.7 0.8 and0.8
1.1, respectively (P  .2 for both vs preischemic control).
During acute pLCx coronary artery occlusion, however, MR
increased significantly from0.5 0.5 to2.0 1.1 (P
.007), with one animal having severe regurgitation, 2 having
moderate regurgitation, 2 having mild-to-moderate regurgi-
tation, and 1 having mild regurgitation. The origin of the
MR jet by means of color Doppler echocardiography was
TABLE 1. Hemodynamics
LAD dLCx pLCx
Before ischemia Ischemia Before ischemia Ischemia Before ischemia Ischemia
HR (min1) 96 14 100 16 98 17 92 25 103 14 83 20
LV dP/dtmax (mm Hg/s) 1453 512 993 377* 1730 545 1192 417* 1596 545 979 300
EDV (mL) 155 40 162 38 155 35 162 42 156 37 166 41*
ESV (mL) 118 37 137 42* 114 28 129 35* 117 31 138 33*
SV (mL) 37 10 27 6* 42 12 32 9* 39 9 29 9*
LVESP (mm Hg) 60 6 47 11* 64 11 55 16 75 9 47 16*
LVPmax (mm Hg) 103 11 74 14* 114 10 85 21* 116 13 73 21*
HR, Heart rate; dP/dtmax, maximum positive rate of change of LV pressure; EDV, LV end-diastolic volume; ESV, LV end-systolic volume; SV, stroke volume;
LVESP, end-systolic LV pressure; LVPmax, maximum LV pressure.
*P  .05 versus before ischemia.
TABLE 2. Valve-closure times
Valve-closure time (ms)
P valueBefore ischemia Ischemia
LAD
ACOM 61 19 66 22 .64
CENT 56 18 63 23 .35
PCOM 67 31 72 24 .73
dLCx
ACOM 51 16 73 31 .12
CENT 47 20 59 42 .32
PCOM 54 28 63 34 .49
pLCx
ACOM 58 29 92 24 .049
CENT 52 26 92 23 .025
PCOM 60 30 94 14 .028
LAD, LAD coronary artery occlusion; ACOM, leaflet edge marker pair near the anterior commissure; CENT, leaflet edge marker pair at valve center; PCOM,
leaflet edge marker pair near the posterior commissure; dLCx, dLCx coronary artery occlusion; pLCx, pLCx coronary artery occlusion.
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Figure 3. Leaflet edge separation for all animals before (filled squares) and during (open circles) acute LV ischemia
induced by balloon occlusion of either the LAD coronary artery (top row), the dLCx coronary artery (middle row),
or the pLCx coronary artery (bottom row). Leaflet edge separation was measured near the anterior commissure
(ACOM, left column), at the valve center (CENT, middle column), and near the posterior commissure (PCOM, right
column). A 650-ms time interval centered at end diastole (t  0) is shown for all 3 groups.
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central in 5 of the 6 animals and posterolateral in 1 of the
animals. Evaluation of the timing of the regurgitant jet was
feasible in 4 animals: all 4 had holosystolic MR.
Mitral Valve Closure and Leaflet Edge Separation
Valve-closure times with respect to end diastole for each
ischemic intervention and at each leaflet edge marker pair
location (anterior commissure, valve center, and posterior
commissure) are summarized in Table 2. Neither LAD nor
dLCx coronary artery occlusion altered valve-closure time,
but pLCx coronary artery occlusion significantly delayed
valve closure at all 3 leaflet locations. Leaflet edge separa-
tion throughout the cardiac cycle for each leaflet edge
marker pair during the 3 ischemic interventions is shown in
Figure 3. Delayed early systolic valve closure (leaflet loi-
tering) was observed during pLCx coronary artery occlusion
but not during LAD or dLCx coronary artery occlusion.
Leaflet edge separation was greater during systole versus
preischemic control conditions during pLCx coronary artery
occlusion, but this was not observed during the other 2
ischemic interventions (Figure 3). Leaflet edge separation
distance was calculated at 25%, 50%, 75%, and 100% of LV
ejection (Table 3) and was larger at all times and in all 3
coaptation regions during pLCx coronary artery occlusion
compared with that seen during preischemic control condi-
tions. The increase in systolic leaflet edge separation (aver-
age of the 4 time points during ejection) during pLCx
coronary artery occlusion was 2.2 1.5 mm, 2.1 1.9 mm,
and 2.1  1.5 cm at the anterior commissure, valve center,
and posterior commissure, respectively (all P  .05). No
significant changes were observed during LAD coronary
artery ischemia, and in only 2 instances did leaflet edge
separation increase during dLCx coronary artery ischemia.
Mitral Annular Dynamics
Mitral annular area change during the cardiac cycle during
each ischemic intervention is shown in Figure 4. Table 4
summarizes mitral annular area and S-L and C-C annular
diameter measurements at end diastole during the 3 differ-
ent ischemic interventions and the preischemic control con-
ditions. The greatest amount of annular dilatation was ob-
served during end diastole and beginning systole. Although
significant annular dilatation (7% 5%) was also present at
end diastole during dLCx coronary artery ischemia, this was
TABLE 3. Leaflet edge separation during ejection
Leaflet edge separation (mm) at % LV ejection
Before ischemia Ischemia
25% 50% 75% 100% 25% 50% 75% 100%
LAD
ACOM 3.7 1.2 3.5 1.0 3.5 0.9 3.7 1.1 4.6 1.9 4.3 1.6 4.1 1.4 4.1 1.4
CENT 4.7 1.9 4.6 1.7 4.5 1.6 4.7 1.8 4.9 2.1 4.7 1.9 4.5 1.9 4.5 1.5
PCOM 6.9 2.5 6.7 2.6 6.5 2.6 6.8 3.0 7.4 2.9 7.0 2.9 6.7 2.9 6.9 2.9
dLCx
ACOM 3.6 1.1 3.5 1.1 3.3 1.0 3.4 1.1 4.2 1.6* 4.0 1.6 4.0 1.7 4.2 1.8
CENT 4.3 1.9 4.3 1.8 4.3 1.8 4.1 1.2 4.7 2.0 4.6 1.9 5.1 1.7 4.9 1.4
PCOM 6.6 2.8 6.5 2.7 6.3 2.8 6.2 2.8 7.2 2.9 7.2 2.8 7.1 2.8 7.0 2.8*
pLCx
ACOM 3.2 0.8 3.3 0.7 3.3 0.7 3.4 0.7 6.2 1.8* 5.2 1.4* 4.9 1.5* 5.7 2.0*
CENT 4.0 1.9 4.3 1.8 4.1 1.9 4.3 1.8 6.8 1.8* 5.6 1.7* 5.5 1.6* 7.4 2.3*
PCOM 6.6 2.7 6.4 3.0 6.3 3.0 6.4 3.0 8.9 2.7* 8.3 2.9* 8.2 3.0* 8.5 3.0*
LAD, LAD coronary artery occlusion; ACOM, leaflet edge marker pair near the anterior commissure; CENT, leaflet edge marker pair at valve center; PCOM,
leaflet edge marker pair near the posterior commissure; dLCx, dLCx coronary artery occlusion; pLCx, pLCx coronary artery occlusion.
*P  .05 versus before ischemia.
TABLE 4. Mitral annular dynamics during LAD, pLCx, and dLCx occlusion
LAD dLCx pLCx
Before ischemia Ischemia Before ischemia Ischemia Before ischemia Ischemia
MAAED (cm
2) 7.39 2.02 7.59 1.44 7.25 1.71 7.76 1.78* 7.11 1.51 8.46 2.01*
SLED (cm) 2.64 .32 2.77 .20 2.61 .24 2.79 .25* 2.57 .20 3.02 .30*
CCED (cm) 3.64 .52 3.68 .44 3.66 .47 3.67 .47 3.63 .44 3.75 .50
LAD, LAD coronary artery occlusion; dLCx, dLCx coronary artery occlusion; pLCx, pLCx coronary artery occlusion; MAAED, End-diastolic mitral annular area;
SLED, end-diastolic mitral annular septal-lateral diameter; CCED, end-diastolic mitral annular commissure-commissure diameter.
*P  .05 versus before ischemia.
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not associated with IMR. During pLCx coronary artery
ischemia, however, mitral annulus area increased much
more (19%  10%) and was associated with IMR. Simi-
larly, the degree of mitral S-L diameter increase was much
greater during proximal versus dLCx coronary artery occlu-
sion (18%  9% vs 7%  4% at end diastole, P  .009).
Interestingly, the IMR, which occurred during pLCx coro-
nary artery occlusion, was not associated with any signifi-
cant increase in the mitral annular C-C dimension.
Papillary Muscle Displacement, Geometry, and
Systolic Shortening
The distance in 3-D space between each papillary muscle tip
and the midseptal annulus was calculated for each ischemic
intervention to assess the effects of regional ischemia on LV
geometry and the pathogenesis of IMR. The midseptal an-
nulus was chosen as a reference site because it represents
the center of the anterior fibrous annulus (which is relatively
fixed and less influenced by the geometric perturbations
induced by acute ischemia), is an identifiable echocardio-
graphic landmark, and has been used previously in similar
experimental studies.18 At end systole, LAD coronary artery
occlusion was associated with 1.1  0.6 mm displacement
of the posterior papillary tip away from the anterior mitral
annulus (P  .005 vs preischemic control), and a similar
displacement of 1.0  1.0 mm was seen during dLCx
coronary artery occlusion (P  .046 vs preischemic con-
trol). During pLCx coronary artery ischemia, however, the
displacement of the posterior muscle more than doubled
(2.6  0.8 mm, P  .0005), and there also was a 1.5  0.9
mm (P  .003) displacement of the anterior papillary mus-
cle away from the midseptal annulus. These changes
throughout the cardiac cycle are shown in Figure 5. Thus
significant IMR seen during pLCx coronary artery occlusion
was associated with displacement of both papillary muscle
tips away from the anterior annulus.
Papillary muscle shortening was calculated to assess
whether papillary muscle dysfunction played a role in the
pathogenesis of acute IMR. During LAD coronary artery
occlusion, anterior papillary muscle shortening decreased
from 15%  4% to 3%  4% (P  .003), but posterior
papillary muscle shortening did not change (16%  7% vs
16%  8%). With dLCx coronary artery occlusion, there
was no change in anterior papillary muscle shortening (14%
 8% vs 14%  9%), but posterior papillary muscle short-
ening was markedly reduced (16%  8% vs 1.2%  0.6%,
P  .02), yet no IMR was seen. pLCx coronary artery
occlusion produced a similar pattern of changes in papillary
muscle shortening, as seen during dLCx coronary artery
occlusion (12%  8% and 1%  5% shortening for the
anterior and posterior papillary muscles, respectively).
These findings argue that isolated lack of systolic shortening
of one or both papillary muscles does not affect mitral valve
competence. The distance between the papillary muscle tips
at end-systole during LAD and dLCx coronary artery oc-
clusion was larger than the respective preischemic control
conditions (increase of 2.7  1.9 mm and 4.3  2.3 mm for
LAD and dLCx coronary arteries, respectively; P  .05),
but a much greater degree of papillary muscle tip separation
occurred during pLCx coronary artery occlusion (7.2  1.6
mm, P  .0001), suggesting greater perturbation of subval-
vular 3-D geometry.
Discussion
IMR has been attributed to annular5,6 and subvalvular7-12
pathologic changes, altered leaflet geometry,10,14 and sys-
tolic dysfunction13 resulting from posterolateral ischemia,
but these findings have not been evaluated in vivo during
ischemia in other LV regions. The current study revealed
that the extent of LV hemodynamic impairment did not
directly cause acute IMR; only pLCx coronary artery oc-
clusion resulted in acute IMR and not LAD or dLCx coro-
nary artery occlusion. Analysis of 3-D marker measure-
ments showed delayed early systolic valve closure and
Figure 4. Average mitral annular (MA) area (in square centime-
ters) before (filled squares) and during (open circles) acute LV
ischemia induced by balloon occlusion of either the LAD artery
(top), the dLCx coronary artery (middle), or the pLCx coronary
artery (bottom). A 650-ms time interval centered at end diastole
(t  0) is shown for all 3 groups.
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incomplete leaflet coaptation throughout systole across the
entire valve. The IMR leak was predominantly central and
was holosystolic.
We have previously reported that acute IMR in sheep
was associated with delayed early systolic mitral valve
closure.5 In the current experiment we observed this leaflet
loitering in early systole at the center of the valve and also
toward the commissures during pLCx coronary artery oc-
clusion, which was accompanied by IMR. During LAD and
dLCx coronary artery ischemia, delayed valve closure was
not observed, and no significant IMR resulted. In addition to
delayed early systolic mitral valve closure, incomplete mi-
tral leaflet coaptation was seen throughout ejection during
pLCx coronary artery ischemia. Leaflet edge separation
throughout ejection increased by a similar extent at the
valve center and at each commissure. Again, as with early
systolic leaflet loitering, increased leaflet edge separation
was only observed in conjunction with pLCx coronary
artery occlusion but not during either LAD or dLCx coro-
nary artery occlusion. Holosystolic leaflet edge separation
was not observed in our previous study,5 probably because
of a smaller ischemic insult and the fact that fewer leaflet
markers were implanted. Therefore it appears that acute
IMR in sheep is due to at least 2 underlying factors: delayed
early systolic mitral valve closure and increased leaflet edge
separation during the bulk of ejection.
The underlying geometric perturbations directly respon-
sible for IMR are difficult to isolate. Previous ovine studies
suggested that delayed early systolic valve closure was due
to annular dilatation5; in the current study, during pLCx
coronary artery occlusion, annular dilatation was associated
with IMR and leaflet loitering, whereas lesser degrees of
annular dilatation during either LAD or dLCx coronary
artery occlusion did not result in either IMR or delayed
valve closure. This emphasizes the point that modest de-
grees of annular dilatation do not necessarily lead to acute
IMR.19 The increase in the S-L annular diameter appeared
to be key, whereas no dilatation was observed in the C-C
distance. Thus increasing the annular dimension perpendic-
ular to the line of leaflet coaptation (ie, S-L dilatation)
probably plays a major role in delaying leaflet closure in
early systole and increased leaflet separation subsequently
throughout systole.
Restricted systolic leaflet motion caused by apical teth-
Figure 5. Group mean data for the distance from the posterior (left panel) and anterior (right panel) papillary muscle
tips to the midseptal annulus before and during occlusion of each of the 3 coronary artery sites: LAD coronary
artery (top), dLCx coronary artery (middle), or pLCx coronary artery (bottom). A 650-ms time interval centered at end
diastole (t  0) is shown for all graphs.
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ering or tenting, presumably from papillary muscle dis-
placement, has also been observed in ovine acute IMR.14
Several investigators have postulated that perturbation of
papillary muscle geometry prevents competent leaflet clo-
sure and results in IMR.6-8 The current analysis revealed
that acute IMR requires displacement of both (but predom-
inately the posterior) papillary muscle tips away from the
septal annulus throughout ejection and at end systole, as was
seen during pLCx coronary artery occlusion (Figure 5).
Such papillary muscle displacement has been found in ex-
perimental8 and clinical6 studies to correlate with the pres-
ence of MR. In animal models of acute20 and chronic18
posterolateral ischemia, a larger distance from the papillary
muscle tips to the midseptal annulus, measured by using
3-D echocardiography, was the only determinant of mitral
regurgitant volume. Mitral annular dilatation was observed
in both studies, being more prominent in the acute model.
Indeed, during acute LCx coronary artery occlusion in dogs,
displacement of the posteromedial papillary muscle tip
away from the midseptal annulus was not sufficient to
produce significant MR when the ventricle was kept small
(intact pericardium and reduced LV preload), and mitral
annular area remained unchanged.20 When the ventricle was
allowed to dilate (open pericardium and increased LV vol-
ume) in this acute canine model, displacement of both (but
particularly the ischemic posteromedial) papillary muscles
tips away from the septal annulus was accompanied by
approximately 22% annular dilatation and substantial MR.
A similar degree of annular dilatation with papillary muscle
displacement during IMR was observed in our experiment.
Whether annular dilatation, papillary muscle displacement,
or both is the mechanism primarily responsible for in-
creased systolic leaflet separation cannot readily be distin-
guished in this model of acute IMR.
Decreased systolic shortening of either papillary muscle
did not result in MR, which corroborates the findings of
others21 and is an additional demonstration that the old
belief of papillary muscle dysfunction being responsible for
IMR is invalid. Indeed, papillary muscle dysfunction has
actually been demonstrated to ameliorate the severity of
IMR.22 As suggested in the clinical literature,23,24 an addi-
tional insult to the LV wall underlying the papillary muscles
is needed before valvular incompetence occurs. This notion
is supported by the increased interpapillary distance and
larger LV end-diastolic volume associated with IMR during
pLCx coronary artery occlusion but not during dLCx coro-
nary artery occlusion. This implies that a mild degree of LV
chamber dilatation per se does not necessarily lead to IMR,
as suggested by the very small and insignificant increase in
LV end-diastolic volume seen with LAD occlusion (P 
.065); instead, the specific regional site and size of ischemic
insult are actually more important. On the basis of ovine
coronary artery anatomy and blood supply to the papillary
muscles,25 one would expect that both proximal and dLCx
coronary artery ischemia would result in posterior papillary
muscle dysfunction, whereas LAD occlusion would affect
anterior papillary muscle shortening. This was indeed ob-
served in our study, yet IMR occurred only with pLCx
coronary artery occlusion, probably because of the large
area of underlying ischemic myocardium, which is associ-
ated with such an ischemic insult.25 IMR in this experiment
was not associated with reduced LV dP/dt, as previously
suggested.13 Although a similar degree of LV systolic dys-
function was induced by the 3 ischemic interventions (Table
1), only pLCx coronary artery occlusion caused IMR. Oth-
ers have also reported that the presence of IMR is not
dependent on the degree of LV systolic dysfunction.6,8
These data further support the hypothesis that regional
alterations in valvular and subvalvular geometry play an
important role in the pathogenesis of IMR.
There is a paucity of in vivo experimental data in the
literature reporting the timing and location of IMR, but
transesophageal echocardiography clinically is accurate in
localizing the origin of the mitral regurgitant jets,26 includ-
ing those of ischemic cause.27 Reports of in vitro studies of
isolated porcine mitral valves are concordant with the echo-
cardiographic and marker-derived findings reported herein.
In an isolated in vitro beating heart preparation, He and
colleagues7 found that with annular dilatation and apical-
posterolateral papillary muscle displacement, as can be seen
in patients with IMR, MR occurred and was holosystolic,
with prominent early and late systolic peaks. Using a similar
experimental preparation, Nielsen and coworkers9 observed
that displacement of both papillary muscles resulted in
central MR. Annular dilatation as a consequence of previous
myocardial infarction and LV dilatation in patients is com-
monly associated with central functional MR.28 Because
both annular dilatation and displacement of both papillary
muscle tips were observed in this acute experiment, the
finding of holosystolic, central MR during pLCx coronary
artery occlusion is consistent with these clinical observa-
tions. During pLCX coronary artery occlusion, leaflet sep-
aration distance was increased throughout systole at the
valve center and also near each commissure, again demon-
strating the occurrence of a broad central origin for the
regurgitant jet. Not all patients with clinically significant
IMR, however, have an echocardiographically demon-
strated central regurgitant jet29; thus acute ovine IMR prob-
ably does not completely simulate the chronic IMR condi-
tion observed in human subjects.
The IMR during pLCx coronary artery occlusion in this
experiment was accompanied by delayed early systolic
valve closure and increased leaflet edge separation through-
out ejection symmetrically around the valve center. Acute
LV ischemic insults in other regions (ie, during LAD and
dLCx coronary artery occlusion) did not lead to IMR, de-
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layed leaflet closure, or increased leaflet edge separation.
We conjecture that annular dilatation was the key factor
leading to delayed leaflet closure, whereas annular dilata-
tion plus papillary muscle displacement during ejection
caused increased leaflet edge separation. The individual
contributions of these multiple mechanisms to the patho-
genesis of IMR are difficult to isolate, but it is clear that the
combination of valvular and ventricular geometric changes
leads to central, holosystolic acute IMR in sheep.
Although this study overcomes some limitations of pre-
vious experiments, one must be circumspect in interpreting
the results. These findings pertain only to the context of
acute LV ischemia in the otherwise normal sheep hearts and
should not be extrapolated to chronic human IMR, where
LV dilatation, subvalvular geometric perturbations induced
by previous infarction and ischemia, and LV remodeling
most likely play a bigger role. This type of experiment
needs to be conducted in chronic animal preparations after
myocardial infarction with resultant LV remodeling and
chronic LV volume overload to simulate more accurately
the clinical problem. The present experiment, however,
offers a unique opportunity to study the effects of annular
and subvalvular geometric changes during 3 different re-
gional LV ischemic insults in the same hearts, which cannot
be done in a chronic model. Although the degree of systolic
dysfunction induced by each ischemic intervention was
similar, LV dP/dt (an isovolumic index) during pLCx cor-
onary artery ischemia might have been artificially high
because this was the only group with significant mitral
insufficiency. Although this raises the possibility that the
magnitude of the acute ischemic injury was greater during
pLCx coronary artery occlusion, other indices of LV func-
tion decreased to a similar extent, suggesting equivalent
hemodynamic insults.
The timing of IMR could be determined reliably in only
4 animals, and not all 6 animals had a central regurgitant jet;
perhaps with more animals greater heterogeneity of regur-
gitant jets would have been observed. The differences in
coronary anatomy between sheep and human subjects must
also be considered because sheep left ventricles are more
dependent on their dominant LCx coronary artery than
human ventricles, in which right coronary artery dominance
is most common. Several reliable models of human cardiac
disease, however, have been established in ovine mod-
els.25,30 The radiopaque marker method provides reproduc-
ible determination of 3-D marker position with submillime-
ter spatial resolution every 16.7 ms but requires suturing
small metal markers to the intracardiac structures. It is
unlikely that the markers interfere with mitral leaflet motion
because they are very small (aggregate mass, 20  6 mg);
even when we grossly overloaded the anterior leaflet with a
larger number of excessively heavy markers (total mass,
184 mg) in other animals, the peak anterior leaflet opening
velocity by means of epicardial pulsed wave Doppler echo-
cardiography was unchanged (0.47  0.05 m/s compared
with 0.45  0.06 m/s for leaflets without any markers
implanted), as was the peak E-wave velocity (0.55 to 0.60
m/s, unpublished data).
We acknowledge the superb technical assistance provided by
Carol W. Mead, BA, and Maggie Brophy, RVT.
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Discussion
Dr Henry M. Spotnitz (New York, NY). This is a very nice article
and a very good use of the marker technique that was pioneered at
Stanford. I would like to ask you a methodologic question. It is a
bit unusual not to randomize a sequence of interventions. How did
you arrive at that particular sequence of interventions, why didn’t
you randomize the order in which you did the various occlusions,
and how do you know that your observations are not a function of
the sequence in which you did this, especially because the appear-
ance of many of the control tracings change over time and the
controls clearly are not identical, particularly in the leaflet sepa-
ration tracing that you showed?
Dr Timek. That is an excellent question. Our initial sequence
of doing the occlusions really came from previous experiments.
What we have noticed is that in sheep that undergo a pLCx
coronary artery occlusion there is a very high frequency of ven-
tricular fibrillation, and in a closed-chest preparation, once these
animals go into ventricular fibrillation, the experiment is basically
over. Therefore the way we proceeded was to induce the ischemic
event, which is less likely to produce ventricular fibrillation first,
that being LAD ischemia, dLCx, and then, at the end, pLCx.
Between each of these interventions, the animals were allowed
to come to baseline as far as hemodynamics were concerned;
however, you are correct, we cannot fully exclude that the se-
quence of the experiments somehow did not contribute to this. We
are considering repeating this in an open-chest model in which
ventricular fibrillation, when it does occur, can be treated much
more easily.
Dr David H. Adams (New York, NY). I really enjoyed your
talk. In the clinical setting ischemia in any circulatory territory can
result in the phenomena of IMR, presumably on the basis of
associated ventricular dilatation and papillary muscle displace-
ment. Would you please comment on the mechanism of IMR in the
setting of LAD occlusion or posterior descending artery occlusion,
as opposed to pLCx occlusion?
Dr Timek. I think that one of the major limitations of this
model is that this is acute IMR. We believe that some new data
from our laboratory with chronic IMR, which has just been com-
pleted by my colleague, Dr Tibayan, shows that these changes in
the chronic model are actually pretty similar to what we see in the
acute model as far as pLCx coronary artery occlusion is concerned.
We did not do any LAD ischemia in the chronic model, and that
will be forthcoming.
As far as translating this into the clinical arena, the feeling is that
clinical IMR is related to LCx ischemia and papillary muscle dis-
placement. From our chronic and acute models, we believe that you
really need both annular changes and you also need displacement of
papillary muscles, and this really gets into how one should address
IMR clinically. Is a ring sufficient, addressing basically the annular
problem, or should there be some subvalvular interventions also? We
have been working on some experimental surgical techniques to
address these problems; however, this is still in its infancy.
Dr Adams. Just to follow up, I have one quick question about
the research you just mentioned. Are you and Dr Miller’s labora-
tory able to give us at least some insight into your comment? What
geometric parameter might suggest that reduction annuloplasty is
going to work, and would not further displacement or measure-
ment of the papillary muscles suggest that we need to think about
some papillary remodeling as well?
Dr Timek. If I may be allowed to give a prelude to my
colleague’s research, it is annular dilatation, at least in our models,
which is really the key, particularly septal lateral dilatation. We
presented an article last year just with isolated septal lateral re-
duction by a single suture that an acute model of IMR in sheep will
abolish IMR. As far as the papillary muscle displacement is
concerned, what we have found, surprisingly, is that there is
displacement of the posterior papillary muscle, which is lateral and
posterior but not apical. The muscle is not actually apically dis-
placed, it is posterior and lateral, and in fact, it seems to move
closer to the annular plane. There have been some suggestions of
perhaps pulling the muscle up closer to the annulus. Whether that
will work is difficult to say.
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